Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cellceutix Corp.
DescriptionOral rinse formulation of a synthetic defensin mimetic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationMucositis
Indication DetailsPrevent oral mucositis (OM); Treat and prevent oral mucositis (OM)
Regulatory Designation U.S. - Fast Track (Prevent oral mucositis (OM))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today